We suspect that serial engagements of TCR Vβ3 CD8+ T cells with superantigen-coated tumor cells ultimately led to decreased numbers of these exhausted CD8+ T cells in the TME by the completion of treatment C4. Here, CD8A is linked to neoplasm.